China Pharma Holdings (CPHI) Receivables (2010 - 2026)
China Pharma Holdings' Receivables came in at $248,248 for Q2 2026, down 21.7% from $317,154 a year earlier and down 3.7% from the prior quarter.
Powered by 
Analysis
China Pharma Holdings (CPHI) Receivables (2010 - 2026) Analysis & Trends
At the end of FY2025, China Pharma Holdings' Receivables was $290,673, up 10.8% from FY2024.
- Receivables carries a five-year compound annual growth rate of -17.7% (FY2020 to FY2025).
- Going back by year, Receivables was $262,426 in FY2024 (-60.4%), $662,392 in FY2023 (-57.1%), $1.54 million in FY2022 (+6.1%) and $1.45 million in FY2021 (+89.4%).
- The Q2 2026 figure represents the lowest quarterly Receivables since Q1 2023.
- Year-over-year, Receivables increased in two of the last eight quarters, with an average decline of 15.5%.
- The fastest year-over-year change in Receivables over five years came in Q1 2024 (growth of 264.5%), and the weakest in Q1 2023 (a decline of 91.4%).
- Business Quant data shows CPHI's Receivables at $257,919 (Q1 2026), $290,673 (Q4 2025) and $285,913 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | China Pharma Holdings | 29.58 Mn | 28.46 Mn | 83,566.00 | 248,248.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 248,248.00 |
| Mar 31, 2026 | 257,919.00 |
| Dec 31, 2025 | 290,673.00 |
| Sep 30, 2025 | 285,913.00 |
| Jun 30, 2025 | 317,154.00 |
| Mar 31, 2025 | 367,947.00 |
| Dec 31, 2024 | 262,426.00 |
| Sep 30, 2024 | 379,924.00 |
| Jun 30, 2024 | 283,510.00 |
| Mar 31, 2024 | 390,985.00 |
| Dec 31, 2023 | 662,392.00 |
| Sep 30, 2023 | 397,156.00 |
| Jun 30, 2023 | 275,244.00 |
| Mar 31, 2023 | 107,254.00 |
| Dec 31, 2022 | 450,670.00 |
| Sep 30, 2022 | 1.14 Mn |
| Jun 30, 2022 | 1.20 Mn |
| Mar 31, 2022 | 1.24 Mn |
| Dec 31, 2021 | 1.45 Mn |
| Sep 30, 2021 | 1.75 Mn |
API Access
China Pharma Holdings Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=CPHI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "CPHI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=CPHI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();